Leaflet PITIPIX 4mg film-coated tablets

Product code:
W70816001
Quantity:
7
Indicated for:
dyslipidemia
Route of administration:
oral
Substance:
pitavastatin (statin lipid-lowering agent)
ATC
C10AA08 — Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors

Precautions:

Hepatotoxicity

Hepatotoxicity

This medicine may affect the liver.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Myopathy / rhabdomyolysis

Myopathy / rhabdomyolysis

Seek medical advice if unexplained muscle pain occurs.

Requires periodic laboratory tests

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Pitavastatin is a medication used to lower cholesterol and triglyceride levels in the blood, indicated for the prevention of cardiovascular diseases. It belongs to the statin class and works by inhibiting the HMG-CoA reductase enzyme, which is responsible for cholesterol synthesis in the liver.

The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important to combine the treatment with a healthy diet and regular exercise to maximize benefits.

Side effects may include muscle pain, nausea, headache, or elevated liver enzymes. In rare cases, severe adverse effects such as rhabdomyolysis may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases, to ensure the safe use of pitavastatin.

General data about PITIPIX 4mg

Substance:
pitavastatin
Date of latest medicines list:
01-02-2025
Product code:
W70816001
Concentration:
4mg
Pharmaceutical form:
film-coated tablets
Quantity:
7
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
KRKA D.D., NOVO MESTO - SLOVENIA
Holder:
KRKA D.D., NOVO MESTO - SLOVENIA
Number:
15743/2024/01
Shelf life:
3 years

Concentrations available for pitavastatin

  • 1mg
  • 2mg
  • 4mg

Combinations with other substances